Wearables in metastatic gastroenteropancreatic neuroendocrine tumors (NETFIT)

#3159

Introduction: Patients diagnosed of an advanced neuroendocrine tumor (NET) are frequently deteriorating their quality of life due to tumor volume and growth, hormone-release related symptoms and treatment toxicity. Changes on lifestyle (exercise, nutrition and quality of sleep) of patients with solid tumors have been shown to improve treatment compliance, tolerability, as well as in quality of life. However, patients with NETs have not been included in those studies.

Aim(s): The aim of this trial is to assess the clinical benefit, in terms of quality of life, with using electronic devices in patients with NET.

Materials and methods: We are conducting a prospective, multi-center, observational study that will include 100 patients from 10 Spanish hospitals belonging to Spanish Taskforce Group of Neuroendocrine and Endocrine Tumors (GETNE). This trial will assess and monitor changes on distinct aspects in quality of life by a customized smartphone app linked to an activity tracker.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Molina Cerrillo J, Alonso-Gordoa T, Grande E, Benavent M, Garcia-Carbonero R,

Keywords: neuroendocrine tumor, nutritional and exercise assessment, quality of life, trial in progress,